NEW YORK (GenomeWeb) – The High Court of Australia has ruled that a nucleic acid isolated from the body encoding a BRCA1 protein and harboring variations that confer increased risk of breast and ovarian cancer is not a patentable invention as defined by the country's laws.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.